Published research is not a single body of equally weighted fact. It is a hierarchy, and where a particular finding sits on that hierarchy determines what can honestly be said on the strength of it. This is well established in evidence-based medicine and taught routinely in research methods courses, yet it survives contact with popular writing about peptides almost not at all.
The hierarchy, briefly
In vitro
Work in cells, tissue or purified biochemical systems. This is where mechanism is established: a compound binds a receptor, alters an enzyme rate, changes the behaviour of a cultured cell line.
What it supports is that a mechanism is plausible under controlled conditions. What it does not support is any claim about a whole organism. A cell in a dish has no liver, no circulation, no immune system and no route of elimination.
Animal models
An effect demonstrated in a living organism, with all the systems a dish lacks. This is a substantial step up, and it is where a great deal of peptide research stops.
The limitation is species. Physiology differs, metabolism differs, and effective quantities differ. The history of pharmacology is substantially a history of compounds that worked in rodents and did not work in people. An animal result is genuine evidence and it is not a human result.
Human trials
Controlled studies in people, ideally randomised and blinded with a comparator. This is the only tier that supports conclusions about humans, and it is the tier most research compounds have never reached.
Trials also vary enormously among themselves. A small open-label study and a large randomised controlled trial are both human data and are not equivalent.
Reviews and meta-analyses
Synthesis across many studies. At their best these are the strongest evidence available, because they aggregate and weigh. But a synthesis is never stronger than what it synthesises. A meta-analysis of eleven small, poorly controlled studies is a careful summary of weak evidence.
Where research compounds usually sit
The great majority of compounds discussed as research peptides have in vitro data, frequently have animal data, and often have little or no human trial data. That is a normal position for a compound under investigation. It becomes misleading only when a claim is written as though the compound had climbed higher than it has.
How findings get overstated
Overstatement rarely involves anyone lying. It happens through a sequence of small, individually defensible compressions.
- A paper reports that a compound altered a specific marker in a specific cell line under specific conditions.
- The abstract compresses this to the compound affecting a pathway.
- A summary elsewhere describes the compound as influencing the process that pathway belongs to.
- By the time it reaches a forum, the compound simply does the thing.
Every step is a slight loosening. The endpoint bears no useful relationship to what was measured, and the citation trail still leads back to a real paper, which is what makes it persuasive.
Reading a claim properly
- What was actually measured? Not the conclusion, the endpoint. Frequently narrower than the surrounding prose implies.
- In what system? Cells, an animal model, or people. This single question resolves most disagreements.
- Compared against what? A result without a control group establishes very little.
- How many subjects? Small studies produce unstable results, and striking findings from tiny samples frequently fail to replicate.
- Who is citing it, and does the citation say what they claim? Following a reference back to the source is unglamorous and settles arguments faster than anything else.
Grading systems
Formal grading frameworks exist precisely because this problem is well recognised. They differ in detail but share a structure: strength of evidence is a function of study design, consistency across studies, and how directly the evidence addresses the question being asked.
Any honest summary of a research compound should make its tier explicit. A statement that a compound has extensive preclinical data and limited human data is far more useful, and far more accurate, than a confident sentence with no provenance attached.
The practical point. Knowing the tier does not require a background in statistics. It requires asking what system the result came from, and refusing to let a finding travel further up the hierarchy than the study that produced it.